Researchers at Fred Hutch Cancer Center invented a new screening method called ReLiC that uses CRISPR-Cas9 to test all the ...

Ten Washington state health organizations recently received grants of up to $15,000 from Fred Hutch Cancer Center’s Community ...

Dr. Folashade Otegbeye, facility director of the Therapeutic Products Program at Fred Hutch, works to rapidly translate what ...

At first glance, art and science might seem like opposite worlds — one driven by imagination and emotion, the other by data ...

A study published in Nature shows that certain autoantibodies may influence how cancer patients respond to immunotherapy. Autoantibodies are proteins produced by the immune system and have typically ...

In 2024, Obliteride raised more than $9 million for research at Fred Hutch, contributing to more than $58 million raised since 2013. These funds have fueled urgently needed advances in cancer ...

Celebrate the Annual Celebrity Steak-Out! Join us for an evening of food, fun and philanthropy at Celebrity Steak-Out presented by Brotherton Cadillac Buick GMC. A silent auction and cocktail hour ...

Thomas Legacy Society members feel deeply that cancer and infectious disease must be stopped. They are devoted to inspiring our world-renowned scientists and powering the groundbreaking research that ...

A small observational study out of the U.K. of breast cancer patients found that certain types of chemotherapy can weaken part of the immune system for up to nine months after treatment.

A Fred Hutch study involving postmenopausal, overweight and obese women who took 2,000 IUs of vitamin D daily for a year found that those whose vitamin D blood levels increased the most had the ...